Nicoya Lifesciences Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 93
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $20M
Latest Deal Amount
  • Investors
  • 20

Nicoya Lifesciences General Information

Description

Operator of a biotechnology company intended to improve human life by helping scientists succeed. The company designs and builds a surface plasmon resonance system that is accessible to every scientist, affordable, user-friendly, and can be used for a wide variety of applications from workflow automation to comprehensive research, enabling scientists to focus on analyzing data, publishing literature, and making important connections.

Contact Information

Website
www.nicoyalife.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 29 King Street East
  • Unit B
  • Kitchener, Ontario N2G 2K4
  • Canada
+1 (877) 000-0000

Nicoya Lifesciences Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nicoya Lifesciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 16-Dec-2021 $20M 000.00 Completed Generating Revenue
7. Grant 26-May-2021 000 00.000 Completed Generating Revenue
6. Grant 15-Jun-2020 00000 00.000 Completed Generating Revenue
5. Grant 01-May-2019 00.000 00.000 Completed Generating Revenue
4. Later Stage VC 22-Dec-2017 00.000 00.000 Completed Generating Revenue
3. Accelerator/Incubator 11-May-2016 Completed Generating Revenue
2. Grant 20-Sep-2015 $37.9K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Nicoya Lifesciences’s complete valuation and funding history, request access »

Nicoya Lifesciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biotechnology company intended to improve human life by helping scientists succeed. The company designs an
Other Devices and Supplies
Kitchener, Canada
93 As of 2021
000.00
00000000000 000.00

00000

sse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
00000 0000000 000 00000000
Fremont, CA
000 As of 0000
00000
0.000 0000-00-00
00000000 00000

000000 0

trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
0000000000 000000000 000 00000000000
Oxford, United Kingdom
000 As of 0000
00.000
0.000 0000-00-00
00000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nicoya Lifesciences Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cytek Formerly VC-backed Fremont, CA 000 00000 00000000 00000
000000 00000000 00 Formerly VC-backed Oxford, United Kingdom 000 00.000 00000000 00.000
0000000 0000000000 Formerly VC-backed Menlo Park, CA 000 00000 000000000 00000
00000 00000000000 Formerly VC-backed Marlborough, MA 000 00000 00000000 00000
000000000 Formerly VC-backed Seraing, Belgium 000 00.000 000000&0 00.000
You’re viewing 5 of 9 competitors. Get the full list »

Nicoya Lifesciences Patents

  • 15

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Nicoya Lifesciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3134189-A1 Foldable digital microfluidic (dmf) device using flexible electronic platform and methods of making same Pending 21-Mar-2019 000000000000
CA-3113374-A1 Plasmon resonance system, instrument, and device for measuring molecular interactions Pending 28-Sep-2018 0000000000
EP-3857199-A1 Plasmon resonance system, instrument, and device for measuring molecular interactions Pending 28-Sep-2018 0000000000
CA-3113586-A1 Nanostructures for improved molecular detection Pending 24-Sep-2018 0000000000
EP-3857209-A1 Nanostructures for improved molecular detection Pending 24-Sep-2018 G01N21/554
To view Nicoya Lifesciences’s complete patent history, request access »

Nicoya Lifesciences Executive Team (7)

Name Title Board Seat Contact Info
Ryan Denomme Co-Founder, Chief Executive Officer & President
Colin Calvert Chief Financial Officer
Arjun Sudarsan Chief Technology Officer
Tijana Matovic Co-Founder, Chief Revenue Officer and Vice President of Revenue Operations
David Panzarella Chief Commercial Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Nicoya Lifesciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nicoya Lifesciences Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agilent Technologies Corporation Minority 000 0000 000000 0
Export Development Canada Government Minority 000 0000 000000 0
Whitecap Venture Partners Corporate Venture Capital Minority 000 0000 000000 0
Government of Canada Government 000 0000 000000 0
National Research Council Canada Government 000 0000 000000 0
You’re viewing 5 of 20 investors. Get the full list »

Ready to get started?

Request a free trial